Patents by Inventor Lukasz Piotr Dudek

Lukasz Piotr Dudek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230076506
    Abstract: The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
    Type: Application
    Filed: December 11, 2020
    Publication date: March 9, 2023
    Applicant: RYVU THERAPEUTICS S.A.
    Inventors: Magdalena Izabela ZAWADZKA, Luigi Piero STASI, Maciej Krzysztof ROGACKI, Grzegorz Wojciech CWIERTNIA, Lukasz Piotr DUDEK, Agnieszka Justyna GIBAS, Anna RAJDA, Charles-Henry FABRITIUS, Adam RADZIMIERSKI, Tushar Ravindra MAHAJAN, Marcin Wojciech LES, Karol ZUCHOWICZ, Marek WRONOWSKI, David Jörg SYNAK, Sundara Raghuram TANGIRALA
  • Publication number: 20230055741
    Abstract: The present invention relates to compound-linker constructs and antibody-drug-conjugates of compounds of formula (I) that are useful as modulators of STING (Stimulator of Interferon Genes).
    Type: Application
    Filed: December 11, 2020
    Publication date: February 23, 2023
    Applicant: RYVU THERAPEUTICS S.A.
    Inventors: Magdalena Izabela ZAWADZKA, Luigi Piero STASI, Maciej Krzysztof ROGACKI, Grzegorz Wojciech CWIERTNIA, Lukasz Piotr DUDEK, Agnieszka Justyna GIBAS, Anna RAJDA, Charles-Henry FABRITIUS, Adam RADZIMIERSKI, Tushar Ravindra MAHAJAN, Marcin Wojciech LES, Karol ZUCHOWICZ, Marek WRONOWSKI, David Jörg SYNAK, Sundara Raghuram TANGIRALA
  • Publication number: 20220251082
    Abstract: The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
    Type: Application
    Filed: June 12, 2020
    Publication date: August 11, 2022
    Applicant: RYVU THERAPEUTICS S.A.
    Inventors: Magdalena Izabela ZAWADZKA, Luigi Piero STASI, Maciej Krzysztof ROGACKI, Grzegorz Wojciech CWIERTNIA, Lukasz Piotr DUDEK, Monika Patrycja DOBRZANSKA, Grzegorz Witold TOPOLNICKI, Agnieszka Justyna GIBAS, Anna RAJDA, Sylwia SUDOL, Karolina Maria GLUZA, Charles-Henry FABRITIUS
  • Publication number: 20180148429
    Abstract: The present invention relates to substituted quinoxaline derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    Type: Application
    Filed: May 12, 2016
    Publication date: May 31, 2018
    Inventors: Charles-Henry Robert Yves Fabritius, Mateusz Oktawian Nowak, Katarzyna Anna Wiklik, Aleksandra Barbara Sabiniarz, Marcin Dominik Bien, Anna Malgorzata Buda, Pawel Szczepan Guzik, Krzysztof Roman Jakubiec, Monika Maciuszek, Katarzyna Kwiecinska, Mateusz Michal Tomczyk, Michal Mikolaj Galezowski, Andrzej Gondela, Lukasz Piotr Dudek